We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
GP Nutrition is a nutrition company that creates products meant to deliver sustainable weight loss. This award-winning company was created by Gabriela Peacock, a celebrity nutritionist. It has 13,000 global customers who have bought more than 30,000 packs. In June'19, the company reached trading of £50k per month. It has produced 22 products that are now sold in 30 countries. GP Nutrition has delivered revenue of £377k and an EBITDA of £813,389. Nutrition's vision is to solve the 95% failure rate of diets in the USA and the UK.
days to go: Expired investment: £309,890
Doctaly is  the brand new healthcare platform providing the quickest way to find and book an affordable, face-to-face, same day GP appointment. Choose from their trusted private doctors, at a convenient time and location from just £39.99.
days to go: Expired investment: £807,580
Warwick Acoustics produces Electrostatic Audio Systems for the auto industry. The company is partnered with various car Original Equipment Manufacturers and Tier 1 suppliers to produce and distribute automotive solutions. 
days to go: Expired investment: Withheld
Propelair is a company that has developed the world’s lowest water-flush toilet system. The toilet uses air to propel 1.5 litres of water per flush, saving water when compared to 6-9 litres per flush for conventional toilets. The company has installed nearly 4,000 units in the UK and South Africa. They were awarded the prestigious Horizon2020 grant in 2017 to develop new innovations. It has also been featured in publications such as The Daily Telegraph, London Evening Standard, and The Times. The company will use the investment as working capital and stock acquisition funds to enable growth, in the UK and South Africa and launch into other water-stressed markets like the Middle East, Australia, Hong Kong, and Singapore, and introduce its 'Smart Connected Toilet' to the market. 

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £1,236,245
Mami Wata (MW) is a purpose-led, premium African surf lifestyle brand on a mission to redefine the global surf market. MW asserts that it has collaborated with luxury brand 'Moncler' and partnered with renowned stockists including Mr Porter and Huckberry. It aims to be a contender in the $9 billion global surfing market. The company argues that it manufactures all of its products in Africa, having launched in Cape Town, South Africa in 2017. It has also shipped 1200+ copies of its AFROSURF art book to 39 countries along with funding a surf therapy clubhouse in Harper, Liberia. MW has sold products to 7,500+ customers generating more than £400,000 in revenue to date. The company has featured in global media entities such as CNN, GQ, Wallpaper, Monocle, and HypeBeast. MW will use the investment for its international launch in the USA.
days to go: Expired investment: £1,168,393
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph